| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | CERS Cerus Corp | Corash Laurence M73 | Chief Scientific Officer | Sell | 28,427 | $2.02 | $57,288.20 | -0.6% | -7.1% | -26.8% | |
| Mar 14, 2024 | CERS Cerus Corp | Greenman William Mariner70 | President And CEO | Sell | 125,926 | $2.04 | $256,377.20 | -1.9% | -7.1% | -26.8% | |
| Mar 14, 2024 | CERS Cerus Corp | Jensen Chrystal71 | Chief Legal Officer | Sell | 35,284 | $2.02 | $71,106.93 | -3.4% | -7.1% | -26.8% | |
| Mar 13, 2024 | SIBN Si-Bone, Inc. | Nishimura Mika | Director | Sell | 2,500 | $16.22 | $40,550.00 | -11.4% | -19.0% | -9.3% | |
| Mar 13, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 14,500 | $91.01 | $1,319,695.75 | -26.9% | -6.4% | -26.9% | |
| Mar 13, 2024 | OWLT Owlet, Inc. | Scolnick Kathryn R.69 | Chief Financial Officer | Sell | 7,267 | $4.96 | $36,044.32 | -7.6% | -8.8% | -6.8% | |
| Mar 13, 2024 | UFPT Ufp Technologies Inc | Cardin Steve | Vice President | Sell | 915 | $197.49 | $180,703.50 | -7.9% | +29.4% | +7.2% | |
| Mar 13, 2024 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 3,330 | $16.82 | $56,022.92 | -1.3% | -19.0% | -9.3% | |
| Mar 13, 2024 | NVNO Envveno Medical Corp | Alavi Hamed | Chief Technology Officer | Sell | 8,334 | $6.22 | $51,837.48 | -100% | -24.3% | -55.6% | |
| Mar 13, 2024 | CERS Cerus Corp | Moore Carol78 | SVP Reg. &Quality | Sell | 20,619 | $2.02 | $41,552.92 | -2.0% | -13.3% | -31.5% | |
| Mar 13, 2024 | BLFS Biolife Solutions Inc | Duross Amy63 | Director | Sell | 11,200 | $16.92 | $189,541.10 | -14.9% | +21.6% | +42.3% | |
| Mar 12, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources | Sell | 20,321 | $133.61 | $2,715,006.50 | -3.9% | -13.9% | -47.7% | |
| Mar 12, 2024 | DXCM Dexcom Inc | Leach Jacob Steven55 | EVP Chief Operating Officer | Sell | 14,639 | $134.41 | $1,967,638.24 | -5.1% | -13.9% | -47.7% | |
| Mar 12, 2024 | MMSI Merit Medical Systems Inc | Parra Raul Jr.62 | CFO And Treasurer | Sell | 6,480 | $73.95 | $479,182.20 | -17.7% | +11.2% | +33.1% | |
| Mar 12, 2024 | DXCM Dexcom Inc | Brown Michael Jon72 | EVP Chief Legal Officer | Sell | 8,799 | $134.41 | $1,182,679.75 | -11.0% | -13.9% | -47.7% | |
| Mar 12, 2024 | DXCM Dexcom Inc | Lawver Teri L | EVP Chief Commercial Officer | Sell | 4,764 | $134.41 | $640,332.57 | -6.7% | -13.9% | -47.7% | |
| Mar 12, 2024 | AORT Artivion, Inc. | Getz Matthew A | VP, Human Resources | Sell | 5,000 | $19.94 | $99,719.50 | -10.3% | +16.4% | +17.5% | |
| Mar 12, 2024 | ATR Aptargroup, Inc. | Kampouri Monnas Giovanna | Director | Sell | 2,000 | $142.45 | $284,906.20 | -17.2% | +2.2% | +2.5% | |
| Mar 12, 2024 | DXCM Dexcom Inc | Sayer Kevin R62 | President CEO And Chairman | Sell | 81,007 | $133.36 | $10,802,803.26 | -4.3% | -13.9% | -47.7% | |
| Mar 12, 2024 | NEPH Nephros Inc | Amron Arthur H45 | Director | Buy | 7,000 | $2.45 | $17,129.70 | New | -5.6% | -28.4% | |
| Mar 12, 2024 | DXCM Dexcom Inc | Dolan Matthew Vincent63 | EVP Strategy And Corporate | Sell | 6,710 | $134.41 | $901,895.80 | -12.1% | -13.9% | -47.7% | |
| Mar 12, 2024 | ATRC Atricure, Inc. | Noznesky Justin J67 | Chief Mktg &Strategy Officer | Sell | 1,500 | $36.72 | $55,080.00 | -2.0% | -37.5% | -6.5% | |
| Mar 12, 2024 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 11,661 | $134.41 | $1,567,363.17 | -12.0% | -13.9% | -47.7% | |
| Mar 12, 2024 | ICUI Icu Medical Inc/de | Lopez George A45 | Director | Sell | 3,412 | $103.01 | $351,464.75 | -0.5% | +9.7% | +40.4% | |
| Mar 12, 2024 | AHCO Adapthealth Corp. | Flynn James E62 | 10% Owner, *possible Member Of 10% Group | Sell | 350,000 | $10.90 | $3,815,703.53 | -0.6% | +1.4% | -12.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.